Clinicopathologic factors associated with the development of sunitinib-induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Neiman, Victoria
Gottfried, Maya
Hammers, Hans J.
Eisenberger, Mario A.
Carducci, Michael Anthony
Sinibaldi, Victoria J.
Rosenbaum, Eli
Sarid, David
Gez, Eliahu
Peer, Avivit
Neumann, Avivit
Kovel, Svetlana
Selia, Avishay
Mermershtain, Wilmesh
Rouvinov, Keren
Berger, Raanan
Keizman, Daniel
机构：
[1] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel
[2] Meir Med Ctr, Lung Canc Unit, Kefar Sava, Israel
[3] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[4] Rabin Med Ctr, Dept Oncol, Petah Tiqwa, Israel
[5] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Oncol, IL-69978 Tel Aviv, Israel
[6] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[7] Rambam Hlth Care Campus, Haifa, Israel
[8] Rambam Med Ctr, Dept Oncol, Haifa, Israel
[9] Asaf Harofe Med Ctr, Dept Oncol, Zerifin, Israel
[10] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel
[11] Soroka Med Ctr, Beer Sheva, Israel
[12] Meir Med Ctr, Dept Oncol, Kefar Sava, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15551
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinicopathologic factors associated with the development of sunitinib induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Neiman, Victoria
    Gottfried, Maya
    Hammers, Hans J.
    Eisenberger, Mario A.
    Carducci, Michael Anthony
    Sinibaldi, Victoria J.
    Rosenbaum, Eli
    Sarid, David
    Gez, Eliahu
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Rouvinov, Keren
    Berger, Raanan
    Kejzman, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [2] VEGF single nucleotide polymorphisms (SNPs) and correlation to sunitinib-induced hypertension (HTN) in metastatic renal cell carcinoma (mRCC) patients (pts)
    Kim, J. J.
    Vaziri, S. A.
    Elson, P.
    Rini, B. I.
    Ganapathi, M. K.
    Ganapathi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Cella, David
    Davis, Mellar P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Hahn, Elizabeth A.
    Korytowsky, Beata
    Bhattacharyya, Helen
    Sandin, Rickard
    Beaumont, Jennifer L.
    Matczak, Ewa
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma
    Rini, Brian I.
    Choueiri, Toni K.
    Elson, Paul
    Khasawneh, Mohamad K.
    Cotta, Claudiu
    Unnithan, Jaya
    Wood, Laura
    Mekhail, Tarek
    Garcia, Jorge
    Dreicer, Robert
    Bukowski, Ronald M.
    CANCER, 2008, 113 (06) : 1309 - 1314
  • [5] Hypertension and myelosuppression as biomarkers of sunitinib efficacy in Chinese patients (pts) with metastatic renal cell carcinoma (mRCC)
    Qin, Shukui
    Jin, Jie
    Guo, Jun
    Wang, Jin-Wan
    Zhou, Fang-Jian
    Huang, Yi-Ran
    Ren, Xiu-Bao
    Ye, Ding-Wei
    Pan, Sharon
    Sajben, Peter
    Wang, Qiao
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [6] Renal safety of sunitinib treatment: A prospective study for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Rixe, O.
    Meric, J. B.
    Alexandre, J.
    Goldwasser, F.
    Izzedine, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 36 - 36
  • [7] Skin toxicity of sunitinib: Prospective analysis in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Billemont, B.
    Barete, S.
    Meric, J. B.
    Moguelet, P.
    Frances, C.
    Chosidow, O.
    Goldwasser, F.
    Rixe, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Yu, Changhong
    Kattan, Michael W.
    Hutson, Thomas E.
    Hudes, Gary R.
    Yuan, Jinyu
    Valota, Olga
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma
    Rautiola, Juhana
    Donskov, Frede
    Peltola, Katriina
    Joensuu, Heikki
    Bono, Petri
    BJU INTERNATIONAL, 2016, 117 (01) : 110 - 117
  • [10] Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
    Narayan, Vivek
    Keefe, Stephen
    Haas, Naomi
    Wang, Le
    Puzanov, Igor
    Putt, Mary
    Catino, Anna
    Fang, James
    Agarwal, Neeraj
    Hyman, David
    Smith, Amanda M.
    Finkelman, Brian S.
    Narayan, Hari K.
    Ewer, Steven
    ElAmm, Chantal
    Lenihan, Daniel
    Ky, Bonnie
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3601 - 3609
12345